The Valley Desk

NCT02263079 · Interventional trial

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Overall registry status Completed

Phase 3

Conditions Pediatric Immuno-Tolerant Chronic Hepatitis B

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov